4th Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$45,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Not-for-profit hospital tax exemption - Monitored regulatory proposals for not-for-profit, tax-exempt hospitals stemming from the Affordable Care Act. Advocated against the inclusion of redundant and overly proscriptive reporting requirements in the IRS Form 990 Schedule H. Tracked developments on hospital community health needs assessment requirements.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS)

Health Issues HCR

Shortage of Prescription Drugs - Supported legislation (S. 296, H.R. 2245) that would require greater reporting of possible drug shortages. Monitored congressional activity in search of solutions to ongoing drug shortage problem. Group Purchasing Organizations - Education and outreach efforts regarding the value that GPOs bring to hospitals. Monitored and engaged on congressional investigatory efforts regarding group purchasing and health care supply chain. Independent Payment Advisory Board - (S.668, H.R. 452) - Supported legislation that would repeal the Independent Payment Advisory Board. Unique Device Identification - Urged federal regulators to release regulations establishing a national unique identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007. 340 B (of the Public Health Service Act) Drug Pricing Program - monitored legislative proposals that would expand the 340 B prescription drug pricing program to inpatient hospitals. Confidentiality of Medical Information - tracked and engaged on regulatory efforts stemming from the HITECH Act that would require accounting for disclosures of medical information and enhanced reporting for HIPAA covered entities. Outreach and education efforts with policymakers on VHA initiatives doing to improve hospital clinical performance.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: SENATE; Office of Management & Budget (OMB); Treasury, Dept of; Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 452 (112th), H.R. 2245 (112th), S. 668 (112th), S. 296 (112th)

Medicare/Medicaid MMM

Medicare Physician Payments - Supported efforts to correct sustainable growth rate formula to avoid major cuts in Medicare payments to physicians, but opposed using cuts to hospital payments to help offset the cost of such legislation. H.R. 3630 - opposed provisions in the legislation that would make cuts in hospital payments. Joint Select Committee on Deficit Reduction - Monitored activity of the Select Committee on Deficit Reduction and advocated against cuts to Medicare and Medicaid payments for hospitals.

LobbyistCovered position, as disclosed
EDWARD GOODMAN —
CIDETTE PERRIN —
STEVEN RIXEN —

Contacted: Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Treasury, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3630 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.